The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer. (Q40365814)
Jump to navigation
Jump to search
scientific article published on October 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer. |
scientific article published on October 2005 |
Statements
The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer (English)
Sotaro Miwa
Atsushi Mizokami
Evan T Keller
Jian Zhang
1 October 2005